In summary, IgA anti-β2-gpI antibodies were more frequent in patients with MetS than in controls.
En resumen, anticuerpos IgA anti-β2-GPI fueron más frecuentes en pacientes con SM que en los controles.
Em resumo, anticorpos IgA anti-β2-gpI foram mais frequentes em pacientes com SM do que nos controles.